AP: J&J asks US regulators to OK its one-shot COVID-19 vaccine
Johnson & Johnson asked U.S. regulators Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.
While trials showed this vaccine isn’t as effective as Pfizer or Moderna, experts still say this is encouraging news.
BREAKING: Johnson & Johnson is filing with the FDA for emergency use authorization approval of its single-dose COVID-19 vaccine.
The critical shot could be approved as soon as 10 days from now, and shots would likely start being distributed just 2 days after.@megoliver reports pic.twitter.com/mCO4nFIjYD
— CBS Evening News (@CBSEveningNews) February 4, 2021
